000046341 000__ 01087cam\a22003975i\4500
000046341 001__ 46341
000046341 003__ SzGeWIPO
000046341 005__ 20230511161317.0
000046341 006__ m\\\\eo\\d\\\\\\\\
000046341 007__ cr bn |||m|||a
000046341 008__ 220614s2020\\\\nyu\\\\\o\\\\\000\0\eng\d
000046341 035__ $$a(OCoLC)1335038428
000046341 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000046341 041__ $$aeng
000046341 24500 $$aPharmaceutical patents and access to generic medicines in developing countries.
000046341 264_1 $$a[New York, NY] :$$bThomson Reuters,$$c2020
000046341 300__ $$a1 online resource
000046341 336__ $$atext$$2rdacontent
000046341 337__ $$acomputer$$2rdamedia
000046341 338__ $$aonline resource$$bcr$$2rdacarrier
000046341 4901_ $$aEuropean Intellectual Property Review,$$x0142-0461 ;$$vVolume 42, Issue 2
000046341 542__ $$fhttps://1.next.westlaw.com/Copyright
000046341 588__ $$aCrossref
000046341 590__ $$aPublished online: 2020
000046341 650_0 $$aIntellectual property.
000046341 650_4 $$aPharmaceuticals
000046341 650_0 $$aPatents.
000046341 7001_ $$aAriyarathna, Lasantha,$$eauthor.
000046341 7001_ $$aKariyawasam, Kanchana,$$eauthor.
000046341 7731_ $$tEuropean Intellectual Property Review
000046341 7731_ $$wEIPR
000046341 830_0 $$aEuropean Intellectual Property Review,$$vE.I.P.R. 2020, 42(2), 108-118
000046341 85641 $$uhttps://www.westlaw.com/Document/I2D9F4B00434511EA9FCB9CD65AC1351E/View/FullText.html?transitionType=Default&contextData=(sc.Default)&VR=3.0&RS=cblt1.0&sp=wlnintell-000$$yonline version
000046341 904__ $$aArticle
000046341 980__ $$aEIPR